Stifel Maintains Buy on GE HealthCare Techs, Raises Price Target to $102
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Rick Wise maintains a Buy rating on GE HealthCare Techs and raises the price target from $100 to $102.
September 30, 2024 | 11:43 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst Rick Wise has reiterated a Buy rating for GE HealthCare Techs and increased the price target from $100 to $102, indicating a positive outlook.
The increase in price target from $100 to $102 by Stifel suggests a positive outlook for GE HealthCare Techs. The Buy rating indicates confidence in the company's future performance, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100